Integral Diagnostics Limited (ASX:IDX)

Integral Diagnostics Revenue

In the fiscal year ending June 30, 2026, Integral Diagnostics had annual revenue of 788.62M AUD with 25.73% growth. Integral Diagnostics had revenue of 395.14M in the half year ending June 30, 2026, with 65.72% growth.

• Revenue: 788.62M
• Revenue Growth: +25.73%
• P/S Ratio: 1.10
• Revenue / Employee: 258.65K
• Employees: 3,049
• Market Cap: 867.90M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	788.62M	161.40M	25.73%
Jun 30, 2025	627.22M	157.52M	33.54%
Jun 30, 2024	469.70M	28.94M	6.56%
Jun 30, 2023	440.76M	79.83M	22.12%
Jun 30, 2022	360.93M	10.23M	2.92%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error